Great Basin Scientific Inc (NASDAQ:GBSN) announced the U.S.
Great Basin Scientific Inc (NASDAQ:GBSN), a molecular diagnostic testing company, today reported financial results for the second quarter ended June 30, 2016. Second Quarter …
Great Basin Scientific Inc (NASDAQ:GBSN), a molecular diagnostics company, announced today the commercial launch of its Shiga Toxin Direct Test, the only stand-alone test …
Great Basin Scientific Inc (NASDAQ:GBSN), a molecular diagnostics company, today announced the establishment of Great Basin Health Systems, a sales team formed to expand …
Great Basin Scientific Inc (NASDAQ:GBSN) a molecular diagnostics company, announced that its Shiga Toxin Direct Test is available for use outside of the U.S.
Great Basin Scientific Inc (NASDAQ:GBSN), a molecular diagnostics company, announced today that on June 23, 2016, the Nasdaq Listing Qualifications Panel (the “Panel”) issued …
Great Basin Scientific Inc (NASDAQ:GBSN), a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) issued U.S.
Great Basin Scientific Inc (NASDAQ:GBSN), a molecular diagnostics company, announced today that it has initiated a clinical trial for its Stool Bacterial Pathogens …
Great Basin Scientific Inc (NASDAQ:GBSN), a molecular diagnostics company, today announced it has initiated a clinical trial for its sample-to-result Bordatella Direct Test, …
Great Basin Scientific, Inc. (NASDAQ:GBSN), a molecular diagnostic testing company, today reported financial results for the first quarter ended March 31, 2016.
